Harrow partnerships to support Vevye launch

Harrow announced three partnerships to support the upcoming launch of Vevye, indicated for treating the signs and symptoms of dry eye disease.
The partnerships with PhilRx, Apollo Care and PARx Solutions are expected to expand availability of Vevye (cyclosporine ophthalmic solution 0.1%).
PhilRx is a patient access platform that simplifies prior authorizations and streamlines the insurance coverage process for patients, according to a press release. Apollo Care establishes and manages copay program deployment to improve patient access and affordability, while PARx Solutions assists prescribers

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart